Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas.
Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas. Clin Cancer Res. 2015 Dec 15; 21(24):5612-8.
View in:
PubMed
subject areas
Adenocarcinoma
Adult
Aged
Aged, 80 and over
Biomarkers
Cohort Studies
Combined Modality Therapy
Female
Glycogen Synthase Kinase 3
Glycogen Synthase Kinase 3 beta
Humans
Male
Middle Aged
Neoplasm Staging
Pancreatic Neoplasms
Prognosis
Proportional Hazards Models
Treatment Outcome
authors with profiles
Ross Abrams